[1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
[2] |
Santos DAR, Gaiteiro C, Santos M, et al. MicroRNA biomarkers as promising tools for early colorectal cancer screening-a comprehensive review[J]. Int J Mol Sci, 2023, 24(13): 11023.
|
[3] |
Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480.
|
[4] |
Raza A, Khan AQ, Inchakalody VP, et al. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer[J]. J Exp Clin Cancer Res, 2022, 41(1): 99.
|
[5] |
Andre M, Caobi A, Miles JS, et al. Diagnostic potential of exosomal extracellular vesicles in oncology[J]. BMC Cancer, 2024, 24(1): 322.
|
[6] |
Liguori GL, Kisslinger A. Quality management tools on the stage: old but new allies for rigor and standardization of extracellular vesicle studies[J]. Front Bioeng Biotechnol, 2022, 10: 826252.
|
[7] |
Yimin E, Lu C, Zhu K, et al. Function and mechanism of exosomes derived from different cells as communication mediators in colorectal cancer metastasis[J]. iScience, 2024, 27(4): 109350.
|
[8] |
Ghosh S, Dhar R, Gurudas Shivji G, et al. Clinical impact of exosomes in colorectal cancer metastasis[J]. ACS Appl Bio Mater, 2023, 6(7): 2576-2590.
|
[9] |
Glass SE, Coffey RJ. Recent advances in the study of extracellular vesicles in colorectal cancer[J]. Gastroenterology, 2022, 163(5): 1188-1197.
|
[10] |
Szvicsek Z, Oszvald Á, Szabó L, et al. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors[J]. Cell Mol Life Sci, 2019, 76(12): 2463-2476.
|
[11] |
Li S, Xin K, Pan S, et al. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer[J]. Cell Mol Biol Lett, 2023, 28(1): 28.
|
[12] |
Guo W, Cai Y, Liu X, et al. Single-exosome profiling identifies ITGB3+ and ITGAM+ exosome subpopulations as promising early diagnostic biomarkers and therapeutic targets for colorectal cancer[J]. Research (Wash DC), 2023, 6: 0041.
|
[13] |
Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer[J]. Nature, 2015, 523(7559): 177-182.
|
[14] |
Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: a new source of biomarkers[J]. Mutat Res, 2011, 717(1-2): 85-90.
|
[15] |
Liu J, Ren L, Li S, et al. The biology, function, and applications of exosomes in cancer[J]. Acta Pharm Sin B, 2021, 11(9): 2783-2797.
|
[16] |
Ko SY, Lee W, Naora H. Harnessing microRNA-enriched extracellular vesicles for liquid biopsy[J]. Front Mol Biosci, 2024, 11: 1356780.
|
[17] |
Min L, Zhu S, Chen L, et al. Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs[J]. J Extracell Vesicles, 2019, 8(1): 1643670.
|
[18] |
Shi YJ, Fang YX, Tian TG, et al. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer[J]. J Transl Med, 2023, 21(1): 421.
|
[19] |
Nedaeinia R, Manian M, Jazayeri MH, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer[J]. Cancer Gene Ther, 2017, 24(2): 48-56.
|
[20] |
Yan S, Jiang Y, Liang C, et al. Exosomal miR-6803-5p as potential diagnostic and prognostic marker in colorectal cancer[J]. J Cell Biochem, 2018, 119(5): 4113-4119.
|
[21] |
Zou SL, Chen YL, Ge ZZ, et al. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer[J]. Cancer Biomark, 2019, 26(1): 69-77.
|
[22] |
Teng Y, Ren Y, Hu X, et al. MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression[J]. Nat Commun, 2017, 8: 14448.
|
[23] |
Wang J, Yan F, Zhao Q, et al. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer[J]. Sci Rep, 2017, 7(1): 4150.
|
[24] |
Xu Y, Han J, Zhang X, et al. Exosomal circRNAs in gastrointestinal cancer: role in occurrence, development, diagnosis and clinical application (Review)[J]. Oncol Rep, 2024, 51(2): 19.
|
[25] |
Zhang W, Jiang Z, Tang D. The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications[J]. Clin Transl Oncol, 2022, 24(12): 2305-2318.
|
[26] |
Pan B, Qin J, Liu X, et al. Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer[J]. Front Genet, 2019, 10: 1096.
|
[27] |
Xie Y, Li J, Li P, et al. RNA-Seq profiling of serum exosomal circular RNAs reveals circ-PNN as a potential biomarker for human colorectal cancer[J]. Front Oncol, 2020, 10: 982.
|
[28] |
Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis[J]. Cell Res, 2015, 25(8): 981-984.
|
[29] |
Baassiri A, Nassar F, Mukherji D, et al. Exosomal non coding RNA in LIQUID biopsies as a promising biomarker for colorectal cancer[J]. Int J Mol Sci, 2020, 21(4): 1398.
|
[30] |
Rizk NI, Abulsoud AI, Kamal MM, et al. Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players[J]. Life Sci, 2022, 292: 120325.
|
[31] |
Hu D, Zhan Y, Zhu K, et al. Plasma exosomal long non-coding RNAs serve as biomarkers for early detection of colorectal cancer[J]. Cell Physiol Biochem, 2018, 51(6): 2704-2715.
|
[32] |
Liu T, Zhang X, Gao S, et al. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer[J]. Oncotarget, 2016, 7(51): 85551-85563.
|
[33] |
Zhao Y, Du T, Du L, et al. Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer[J]. Cell Death Dis, 2019, 10(8): 568.
|
[34] |
Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer[J]. Exp Mol Med, 2024, 56(4): 877-889.
|
[35] |
Li X, Wang Q, Wang R. Roles of exosome genomic DNA in colorectal cancer[J]. Front Pharmacol, 2022, 13: 923232.
|
[36] |
Hao YX, Li YM, Ye M, et al. KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population[J]. Oncol Lett, 2017, 13(5): 3608-3616.
|
[37] |
Keerthikumar S, Chisanga D, Ariyaratne D, et al. Exocarta: a web-based compendium of exosomal cargo[J]. J Mol Biol, 2016, 428(4): 688-692.
|
[38] |
Li XX, Yang LX, Wang C, et al. The roles of exosomal proteins: classification, function, and applications[J]. Int J Mol Sci, 2023, 24(4): 3061.
|
[39] |
Malla RR, Pandrangi S, Kumari S, et al. Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers[J]. Asia Pac J Clin Oncol, 2018, 14(6): 383-391.
|
[40] |
Yoshioka Y, Kosaka N, Konishi Y, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen[J]. Nat Commun, 2014, 5: 3591.
|
[41] |
Khushman M, Prodduturvar P, Mneimneh W, et al. The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma[J].Oncotarget, 2021, 12(15): 1490-1498.
|
[42] |
Brocco D, Simeone P, Buca D, et al. Blood circulating CD133+ extracellular vesicles predict clinical outcomes in patients with metastatic colorectal cancer[J]. Cancers (Basel), 2022, 14(5): 1357.
|
[43] |
Li J, Li B, Ren C, et al. The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients[J]. Oncotarget, 2017, 8(60): 101189-101202.
|
[44] |
Zhou GY, Zhao DY, Yin TF, et al. Proteomics-based identification of proteins in tumor-derived exosomes as candidate biomarkers for colorectal cancer[J]. World J Gastrointest Oncol, 2023, 15(7): 1227-1240.
|
[45] |
Chang LC, Hsu YC, Chiu HM, et al. Exploration of the proteomic landscape of small extracellular vesicles in serum as biomarkers for early detection of colorectal neoplasia[J]. Front Oncol, 2021, 11: 732743.
|
[46] |
Gheytanchi E, Saeednejad Zanjani L, Ghods R, et al. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma[J]. J Cancer Res Clin Oncol, 2021, 147(6): 1631-1646.
|
[47] |
Chen Y, Xie Y, Xu L, et al. Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics[J]. Int J Cancer, 2017, 140(4): 900-913.
|
[48] |
Sun Z, Ji S, Wu J, et al. Proteomics-based identification of candidate exosomal glycoprotein biomarkers and their value for diagnosing colorectal cancer[J]. Front Oncol, 2021, 11: 725211.
|
[49] |
Wang W, Zhen S, Ping Y, et al. Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring[J]. Front Oncol, 2024, 14: 1331215.
|
[50] |
Hu L, Liu J, Zhang W, et al. Functional metabolomics decipher biochemical functions and associated mechanisms underlie small-molecule metabolism[J]. Mass Spectrom Rev, 2020, 39(5-6): 417-433.
|
[51] |
Simbari F, McCaskill J, Coakley G, et al. Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology[J]. J Extracell Vesicles, 2016, 5: 30741.
|
[52] |
Donoso-Quezada J, Ayala-Mar S, González-Valdez J. The role of lipids in exosome biology and intercellular communication: Function, analytics and applications[J]. Traffic, 2021, 22(7): 204-220.
|
[53] |
Deng Z, Mu J, Tseng M, et al. Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis[J]. Nat Commun, 2015, 6: 6956.
|
[54] |
Skotland T, Ekroos K, Kauhanen D, et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers[J]. Eur J Cancer, 2017, 70: 122-132.
|
[55] |
Bestard-Escalas J, Reigada R, Reyes J, et al. Fatty acid unsaturation degree of plasma exosomes in colorectal cancer patients: a promising biomarker[J]. Int J Mol Sci, 2021, 22(10): 5060.
|
[56] |
Elmallah MIY, Ortega-Deballon P, Hermite L, et al. Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers[J]. Mol Oncol, 2022, 16(14): 2710-2718.
|
[57] |
Eylem CC, Yilmaz M, Derkus B, et al. Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture[J]. Cancer Lett, 2020, 469: 186-194.
|
[58] |
Paul D, Roy A, Nandy A, et al. Identification of biomarker hyaluronan on colon cancer extracellular vesicles using correlative AFM and spectroscopy[J]. J Phys Chem Lett, 2020, 11(14): 5569-5576.
|
[59] |
Castellanos-Rizaldos E, Zhang X, Tadigotla VR, et al. Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients[J]. Oncotarget, 2019, 10(30): 2911-2920.
|